一项名为“ASAP（尽可能快）”的试验对国际治疗标准提出了新的见解：对于急性髓系白血病（Acute Myeloid Leukemia, AML）患者，高剂量化疗并非移植前的必要步骤，这意味着患者可以更快地进行移植 [1]。

A systematic review finds AML patients receiving anthracycline remission induction therapy face a significant heart failure ...

Study’s Dose Escalation Safety Committee approves initiation of Cohort 2 with fourth patient to receive increase in initial ...

New research maps how bone marrow changes in acute myeloid leukemia disrupt neutrophil development and boost the risk for ...

IDH1 mutations in MDS are crucial for guiding therapy decisions, offering one of the few targetable mutations in this disease ...

Ziftomenib showed significant efficacy in relapsed/refractory NPM1-mutant AML, achieving deep, durable responses in the KOMET-001 trial. The trial enrolled 92 patients, with 23% achieving complete ...

An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. Researchers at Baylor College of Medicine, University of Veterinary ...

Researchers used an 8-protein prognostic score termed the leukemia inflammatory risk score (LIRS) to identify inflammatory proteins with newly diagnosed AML.

A CML diagnosis, often striking young Indian adults, is now more manageable. This guide emphasizes empowering patients by ...